Skip to main
GH

GH Stock Forecast & Price Target

GH Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 63%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Guardant Health is well-positioned for future success due to their established leadership in the liquid biopsy market, their innovative testing technologies, and their potential for expansion into new areas. Combined with their successful collaborations and strong financial performance, the company's positive outlook is supported by their strong fundamentals.

Bears say

Guardant Health is set to face challenges in maintaining its high growth trajectory as competition in the liquid biopsy and precision oncology markets intensifies. Additionally, there is uncertainty surrounding the company's reimbursement dynamics, which could potentially pressure its ASPs. Despite its strong performance in the first quarter, issues with its MCED go-to-market strategy could limit growth in the future.

GH has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 63% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Guardant Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Guardant Health Inc (GH) Forecast

Analysts have given GH a Buy based on their latest research and market trends.

According to 19 analysts, GH has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $128.74, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $128.74, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Guardant Health Inc (GH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.